An FDA Overreaction to Theranos's Implosion Would Harm Patients
Briefly

from www.scientificamerican.com9 months ago
The FDA is proposing a new rule that would require agency approval prior to the implementation of any LDT. Some proponents believe this approval could have prevented Theranos's deception with its diagnostic claims.
www.scientificamerican.comhttps://www.scientificamerican.com/article/an-fda-overreaction-to-theranoss-implosion-would-harm-patients/
A Harvard Medical School psychiatrist warns that the FDA's proposed rule may lead to more harm than good, suggesting a more intensive validation program for LDTs instead.
www.scientificamerican.comhttps://www.scientificamerican.com/article/an-fda-overreaction-to-theranoss-implosion-would-harm-patients/
Read at www.scientificamerican.com
[
|
]